Loading…
Medical Device Nonvisual Accessibility Act of 2024
Legislative Progress
Introduced
January 18, 2024
Latest Action
January 18, 2024
Primary Sponsor
Margaret Wood HassanDemocratic(NH)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,649 other S bills in the 118th — cohort avg 33d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2024 · fourth_quarter · Health Issues
To ensure that home-based medical devices are non-visually accessible to blind Americans. Medical Device Nonvisual Accessibility Act, H.R. 1328 and S. 3621.
Client expense: $20,000 · Firm income: Not reported
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
To ensure that home-based medical devices are non-visually accessible to blind Americans. Medical Device Nonvisual Accessibility Act, H.R. 1328 and S. 3621.
Client expense: $10,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Health Issues
To ensure that home-based medical devices are non-visually accessible to blind Americans. Medical Device Nonvisual Accessibility Act, H.R. 1328 and S. 3621.
Client expense: $20,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Health Issues
To ensure that home-based medical devices are non-visually accessible to blind Americans. Medical Device Nonvisual Accessibility Act, H.R. 1328 and S. 3621.
Client expense: $30,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
H.R. 6743, the Were Addressing the Realities of Menopause Act. S. 3621/H.R. 1328, the Medical Device Nonvisual Accessibility Act. No bill number. Discussed Affordable Care Act enhanced subsidy expiration. No bill number. Discussed respiratory virus prevention. No bill number. Discussed artificial intelligence in health care. No bill number. Discussed Compassionate Care Act. S. 3254/H.R 7222, the Lowering Costs for Caregivers Act.
Client expense: $4,370,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office